Differential expression of CDX2 and GCDFP-15 may help distinguishing primary vs. secondary PPD, which is important for management as the presence of an underlying malignancy impacts clinical course and prognosis. The gene discussed is PIP; the disease is progressive pseudorheumatoid arthropathy of childhood.